lapatinib has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boswell, BA; Musil, LS; VanSlyke, JK | 1 |
| Hoving, S; Russell, NS; Seemann, I; Song, JY; Stewart, FA; te Poele, JA | 1 |
2 other study(ies) available for lapatinib and Fibrosis
| Article | Year |
|---|---|
ErbBs in Lens Cell Fibrosis and Secondary Cataract.
Topics: Capsule Opacification; Cataract; Epithelial Cells; Fibrosis; Humans; Lapatinib; Ligands; Transforming Growth Factor beta | 2023 |
Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Cell Survival; Cells, Cultured; Coronary Vessels; Doxorubicin; Fibrosis; Heart Diseases; Humans; Lapatinib; Male; Mice; Mice, Inbred C57BL; Microvessels; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Pericardium; Quinazolines; Radiation Injuries, Experimental; Receptor, ErbB-2; Trastuzumab; Ventricular Function, Left | 2013 |